Multiple Vertebral Fractures After One Dose of Denosumab

Key Points

• Multiple vertebral fractures occurred in patients after a single dose of denosumab, highlighting a significant concern.
• The rate of fractures increased among individuals with previously low bone density levels, emphasizing vulnerability.
• Analysis focused on patient histories and bone density metrics, showing the need for careful assessment prior to treatment.
• This finding calls for further investigation into the long-term effects of denosumab on fracture risk, especially in vulnerable populations.